Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease.

T, Nyström; MK, Gutniak; Q, Zhang; F, Zhang; JJ, Holst; B, Ahrén; A, Sjöholm

doi:10.1152/ajpendo.00237.2004

Public

Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease.

Shared by NobleBlocks on Sep 7, 2004 • 12:00 AM UTC

Authors:

Nyström T

Gutniak MK

Zhang Q

Abstract

GLP-1 stimulates insulin secretion, suppresses glucagon secretion, delays gastric emptying, and inhibits small bowel motility, all actions contributing to the anti-diabetogenic peptide effect. Endothelial dysfunction is strongly associated with insulin resistance and type 2 diabetes mellitus and may...

Discussions